Nuvectis Pharma NVCT
NASDAQ NVCT
$21.92 +1.20 (+5.79%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nuvectis Pharma (NVCT) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

Nuvectis Pharma's Return on Capital Employed [ROCE] was -272.52% in Q2 2026, down 147.96 percentage points from -124.55% a year earlier and down 109.84 percentage points from the prior quarter.

Analysis

Nuvectis Pharma (NVCT) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Nuvectis Pharma came in at -232.46%, down 34.03 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a three-year change of +29.41 percentage points (FY2022 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -198.43% in FY2024 (-19.70 pp), -178.73% in FY2023 (+83.14 pp) and -261.87% in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2022.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last eight quarters, with an average year-over-year change of -9.52 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2025 (a gain of 83.50 percentage points); the worst was Q2 2026 (a drop of 147.96 percentage points).
  • Per Business Quant data, NVCT's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -162.68% (Q1 2026), -135.49% (Q4 2025) and -133.90% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Nuvectis Pharma 553.12 Mn 553.12 Mn - -272.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -272.52%
Mar 31, 2026 -162.68%
Dec 31, 2025 -135.49%
Sep 30, 2025 -133.90%
Jun 30, 2025 -124.55%
Mar 31, 2025 -138.43%
Dec 31, 2024 -218.99%
Sep 30, 2024 -176.42%
Jun 30, 2024 -166.69%
Mar 31, 2024 -168.58%
Dec 31, 2023 -166.65%
Sep 30, 2023 -126.54%
Jun 30, 2023 -141.49%
Mar 31, 2023 -141.87%
Dec 31, 2022 -116.93%
Sep 30, 2022 -97.75%
Jun 30, 2022 -101.98%
Mar 31, 2022 -174.21%
API Access

Nuvectis Pharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NVCT&period=max&api_key=YOUR_API_KEY